Sims Quoted in Chicago Daily Law Bulletin on New Illinois Waiting Period for Gun Purchases
December 20, 2018
Chicago Daily Law Bulletin
Of Counsel Elgie Sims Jr. was quoted in the Chicago Daily Law Bulletin article, “72-Hour Wait to Buy Any Gun Takes Effect Jan. 1,” about a new, 72-hour waiting period to purchase guns in Illinois. The new law will take effect in January 1, 2019.
Sims, a state senator representing Illinois’ 17th Legislative District, said the measure will give law enforcement more time to run background checks on the potential gun purchaser.
“If an individual is thinking about harming others or harming themselves, they’ve got the ability to do it,” Sims said. “As we know, if a gun or firearm is present, the likelihood that an injury or fatality is going to happen increases. We wanted to make sure that we put the cooling-off period into law so that it applies to all guns.”
(Subscription required)
Sims, a state senator representing Illinois’ 17th Legislative District, said the measure will give law enforcement more time to run background checks on the potential gun purchaser.
“If an individual is thinking about harming others or harming themselves, they’ve got the ability to do it,” Sims said. “As we know, if a gun or firearm is present, the likelihood that an injury or fatality is going to happen increases. We wanted to make sure that we put the cooling-off period into law so that it applies to all guns.”
(Subscription required)
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."